Systematic Review · Vol. 1, Issue 1
M.E. Shoranov, Sh.B. Tanabaeva, Z.S. Kachieva, A.M. Tlenchieva, A.Zh. Kauysbekov, Zh.S. Alibaeva
Microbiome biotherapeutics range from standardized indication-specific products to donor-, recipient- and ecology-informed interventions.
personalized microbiome medicinemicrobiome biotherapeuticsfecal microbiota transplantationdonor-recipient matchingmetagenomicsmetabolomics
Read article →
Systematic Review · Vol. 1, Issue 1
I.R. Fakhradiyev, T.R. Fazylov, A.M. Kondybaeva, A.T. Musaev, N.K. Shaktay, Zh.B. Tileules
Contemporary incretin-based therapy has shifted obesity management from ranking drugs by mean weight loss alone toward selection based on dominant comorbidity, treatment persistence, route preference, tolerability, body composition, and the consequences of withdrawal.
obesityGLP-1tirzepatidesemaglutidepersonalized medicinePRISMA 2020
Read article →
Evidence Map · Vol. 1, Issue 1
B.N. Sadykov, T.M. Saliev, K.K. Toguzbaeva, G.S. Bismildina, A. Tolegenkyzy, D.M. Ospanbekova
Multimodal and generative AI systems are increasingly proposed for clinical decision support, but the literature ranges from pragmatic trials to simulated consultations and benchmark-like evaluations.
multimodal artificial intelligencevision-language modelsgenerative AIclinical decision supporthuman-in-the-loopexternal validation
Read article →
Systematic Review · Vol. 1, Issue 1
A.Sh. Ibrayeva, B.S. Asembekov, L.N. Ibragimova, M.M. Maemerov, D.K. Davletov, K.D. Kovaleva
Circulating tumor DNA is clinically advanced in oncology, but its value differs between molecular residual disease assessment after curative-intent treatment and multicancer early detection in asymptomatic populations.
circulating tumor DNActDNAliquid biopsymolecular residual diseasemulticancer early detectionMCED
Read article →
Systematic Review · Vol. 1, Issue 1
A.G. Shamsutdinova, D.S. Menlyakova, B.O. Minbaev, G.B. Ensebaeva
Personalized bacteriophage therapy selects, adapts, or engineers a phage preparation against a patient clinical isolate. This biological specificity may improve target engagement but complicates standardization and causal inference.
bacteriophage therapypersonalized phage therapyantimicrobial resistancemultidrug resistancephage susceptibility testingantiphage immunity
Read article →